EMD-21049

Single-particle
3.8 Å
EMD-21049
3D View Gallery
Deposition: 02/12/2019
Map released: 25/11/2020
Last modified: 09/12/2020
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-21049

Archive Files (Depositor)

Primary 3D volume (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

Engineered oncolytic adenovirus Ad5-3M

EMD-21049

Single-particle
3.8 Å
EMD-21049
3D View Gallery
Deposition: 02/12/2019
Map released: 25/11/2020
Last modified: 09/12/2020
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Human adenovirus 5
Sample: Human adenovirus 5

Deposition Authors: Emerson CC, Atasheva S, Shayakhmetov DM, Stewart PL
Systemic cancer therapy with engineered adenovirus that evades innate immunity.
Atasheva S , Emerson CC , Yao J , Young C , Stewart PL , Shayakhmetov DM
(2020) Sci Transl Med , 12
PUBMED: 33239388
DOI: doi:10.1126/scitranslmed.abc6659
ISSN: 1946-6242